Clin2
NCT07575230Likely a fitEnrolling by invitation

Pain relief after skin cancer surgery: new drug vs standard

Cutaneous TumorsMohs Micrographic Surgery

Treatments studied

Part of Cancer, Skin clinical trials.

This study compares a new pain medication (suzetrigine) to a common pain reliever (Norco) for people recovering from Mohs micrographic surgery, a specialized procedure to remove skin cancer. The goal is to see if the new medication works better and is safer for post-surgery pain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
75 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • You are 18 to 89 years old
  • You had a skin tumor (cutaneous tumor) removed using Mohs micrographic surgery (MMS)
  • You do not have liver disease or liver problems
  • You are not currently taking medications that interact with a liver enzyme called CYP3A
  • You are willing to take either the new medication (suzetrigine) or the standard medication (Norco) for pain relief

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07843134Not yet recruiting· Phase 4
New pain medicine for skin cancer surgery recovery

This study tests a new non-opioid pain medicine called suzetrigine compared to the usual pain relievers (like ibuprofen and acetaminophen) after skin cancer surgery on the head or neck. The goal is to see if it controls pain just as well with fewer side effects.

Maple Grove, Minnesota
NCT07195669Not yet recruiting· Phase 4
Comparing suzetrigine and Norco for pain after dental or jaw surgery

This study compares two pain relievers after certain dental or jaw surgeries: suzetrigine (a new non-opioid painkiller) and Norco (a hydrocodone/acetaminophen combination). The goal is to see which medicine gives better pain relief after surgery, and to offer a potentially safer option.

New Orleans, Louisiana
NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07796152Not yet recruiting· Phase 4
Comparing pain relief options after knee replacement

This study compares two pain relief approaches after knee replacement surgery to see which works better. If you qualify, you will receive either the study medication or standard care to manage your pain.

Skokie, Illinois

Hear when a new Mohs Micrographic Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.